Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Pregabalin CR vs IR and Food Effect in Healthy Males
NCT02103686Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Nov 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of pregabalin in neuropathic pain, epilepsy, generalized anxiety disorder (GAD) and 1 more (3 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Nov 2012; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic painepilepsygeneralized anxiety disorder (GAD)fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02103686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103686.